Details of the Drug

General Information of Drug (ID: DMCG4JG)

• Drug Name: Solriamfetol
• Synonyms: JZP-110; (R)-2-Amino-3-phenylpropyl carbamate; UNII-939U7C91AI; 939U7C91AI; (2R)-2-amino-3-phenylpropyl carbamate; Solriamfetol [USAN]; Adx-N05 free base; SCHEMBL2739637; O-Carbamoyl-(D)-phenylalaninol; UCTRAOBQFUDCSR-SECBINFHSA-N; ZINC34278783; (R)-2-amino-3-phenylpropyl carbamate; Benzenepropanol, beta-amino-, 1-carbamate, (betaR)-; Benzenepropanol, beta-amino-, carbamate (ester), (R)-; 178429-62-4

Indication

Disease Entry	ICD 11	Status	REF
Excessive daytime sleepiness	MG42	Approved	[1]
Narcolepsy	7A20	Phase 3	[2]

• Affected Organisms: Humans and other mammals
• ATC Code:
  N06BA14: Solriamfetol
  N06BA: Centrally acting sympathomimetics
  N06B: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
  N06: PSYCHOANALEPTICS
  N: NERVOUS SYSTEM
• Chemical Identifiers:
  Formula: C10H14N2O2
  Canonical SMILES: C1=CC=C(C=C1)CC(COC(=O)N)N
  InChI: InChI=1S/C10H14N2O2/c11-9(7-14-10(12)13)6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H2,12,13)/t9-/m1/s1
  InChIKey: UCTRAOBQFUDCSR-SECBINFHSA-N
• Cross-matching ID:
  PubChem CID: 10130337
  CAS Number: 178429-62-4
  UNII: 939U7C91AI
  DrugBank ID: DB14754
  TTD ID: D0M3CV
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)